DR. NAVID MALIK - Corporate Board Profile

NORTHWEST BIOTHERAPEUTICS INC

Filing Date	Source Excerpt
2013-12-03	Dr. Navid Malik was appointed to the Board of Directors in April 2012. ... Dr. Malik is the Head of Life Sciences Research at Cenkos Securities Plc. in the U.K., an independent specialist institutional securities firm. ... Audit Committee The Audit Committee currently consists of Messrs. Farmer, Malik and Jasinowski. ... Compensation Committee The Compensation Committee is responsible for determining the overall compensation levels of our executive officers and administering our stock option plans. ... The Board has adopted a written charter for the Compensation Committee and its current members are Messrs. Farmer, Malik and Jasinowski. ... Nominations Committee The Nominations Committee currently consists of Messrs. Farmer, Malik and Jasinowski. ...
2014-11-26	Dr. Navid Malik 45 Class III Director Dr. Malik is the Head of Life Sciences Research at Cenkos Securities Plc. in the U.K., an independent specialist institutional securities firm. From September 2011 through January 2012, Dr. Malik was the Head of Life Sciences Research at Sanlam (Merchant Securities), a global financial services firm. Dr. Malik was Partner and Head of Life Sciences at Matrix Investment Banking Division, Matrix Group, a financial services firm in London, from December 2008 through September 2011. Dr. Malik was a Senior Pharmaceuticals and Biotechnology Analyst at Wimmer Financial LLP from September 2008 through December 2008, and was the Senior Life Sciences Analyst at Collins Stewart Plc from January 2005 through September 2008. In 2011, Dr. Malik was awarded two Starmine Awards (awarded each year by Thomson Reuters and the Financial Times): Number One Stock Picker in the European Pharmaceutical Sector, and Number Two Stock Picker in the U.K. and Ireland Healthcare Sector. Dr. Malik holds a Ph.D. in Drug Delivery within Pharmaceutical Sciences, as well as degrees in Biomedical Sciences Research (M.Sc.) and Biochemistry and Physiology (B.Sc., joint honors). Dr. Malik also holds an MBA in finance from the City University Business School, London. We believe that Dr. Malik’s extensive experience in the life sciences fields and investment banking sector make him well qualified to serve as a Director. Audit Committee Compensation Committee Nominations Committee
2015-11-06	Dr. Navid Malik Dr. Malik is the Head of Life Sciences Research at Cenkos Securities Plc. in the U.K.... Audit Committee The Audit Committee currently consists of Messrs. Farmer, Malik and Jasinowski. Compensation Committee The Board has adopted a written charter for the Compensation Committee and its current members are Messrs. Farmer, Malik and Jasinowski. Nominations Committee The Nominations Committee currently consists of Messrs. Farmer, Malik and Jasinowski.
2016-12-01	Dr. Navid Malik Dr. Malik was appointed to the Board of Directors in April 2012. Audit Committee The Audit Committee currently consists of Messrs. Farmer, Malik and Jasinowski. Compensation Committee The Board has adopted a written charter for the Compensation Committee and its current members are Messrs. Farmer, Malik and Jasinowski. Nominations Committee The Nominations Committee currently consists of Messrs. Farmer, Malik and Jasinowski. Director Compensation Name Year Total ($) Dr. Navid Malik 2015 150,000
2018-01-09	Dr. Navid Malik. Dr. Malik was appointed to the Board of Directors in April 2012. ... The Audit Committee currently consists of Messrs. Malik and Jasinowski. ... The Compensation Committee ... Its current members are Messrs. Malik and Jasinowski. ... The Nominations Committee currently consists of Messrs. Malik and Jasinowski. ... The following table sets forth certain information concerning compensation paid or accrued to our non-executive directors during the year ended December 31, 2017. ... Dr. Navid Malik ... 2017 ... $ 150,000 ... Total ($) ... $ 150,000 ...
2018-04-09	The Options awarded to Dr. Navid Malik will be exercisable for up to 9,065,000 shares of Common Stock. The Options awarded to Dr. Navid Malik... The Company’s independent directors are supposed to receive a combination of cash and equity compensation. However, to date the independent directors have received no equity compensation (except for one small award of 10,000 options to one director in 2013), and the cash portion of their compensation has been delayed for months and in some cases years (and is currently substantially in arrears).
2019-01-08	Dr. Navid Malik. Dr. Malik was appointed to the Board of Directors in April 2012. ... The Audit Committee currently consists of Messrs. Malik and Jasinowski. ... The Compensation Committee ... current members are Messrs. Malik and Jasinowski. ... The Nominations Committee currently consists of Messrs. Malik and Jasinowski. ... The following table sets forth certain information concerning compensation paid or accrued to our non-executive directors during the year ended December 31, 2018. ... Dr. Navid Malik ... 2018 ... Fees Earned or Paid in Cash ($) $150,000 ... Total ($) $150,000.
2020-03-27	Dr. Navid Malik. Dr. Malik was appointed to the Board of Directors in April 2012. ... The Audit Committee currently consists of Messrs. Malik and Jasinowski. ... The Compensation Committee currently consists of Messrs. Malik and Jasinowski. ... The Conflicts Committee currently consists of Ambassador Black, Mr. Jasinowski and Dr. Malik. ... The Nominations Committee currently consists of Messrs. Malik and Jasinowski.
2021-04-16	Dr. Navid Malik. Dr. Malik was appointed to the Board of Directors in April 2012. ... The Audit Committee currently consists of Messrs. Malik and Jasinowski. ... The Compensation Committee currently consists of Messrs. Malik and Jasinowski. ... The Conflicts Committee currently consists of Ambassador Black, Mr. Jasinowski and Dr. Malik. ... The Nominations Committee currently consists of Messrs. Malik and Jasinowski. ... The following table sets forth certain information concerning compensation paid or accrued to our non-executive directors during the year ended December 31, 2020. ... Dr. Navid Malik 2020 Fees Earned or Paid in Cash ($) 150,000 Option Awards ($) 4,123,000 Total ($) 4,273,000
2022-12-05	Dr. Navid Malik. Dr. Malik was appointed to the Board of Directors in April 2012. ... The Audit Committee currently consists of Messrs. Malik and Jasinowski. ... The Compensation Committee currently consists of Messrs. Malik and Jasinowski. ... The Conflicts Committee currently consists of Ambassador Black, Mr. Jasinowski and Dr. Malik. ... The Nominations Committee currently consists of Messrs. Malik and Jasinowski. ... The following table sets forth certain information concerning compensation paid or accrued to our non-executive directors during the years ended December 31, 2021, December 31, 2020 and December 31, 2019. ... Dr. Navid Malik ... 2021 ... 150,000 ...
2024-06-03	Dr. Navid Malik. Dr. Malik was appointed to the Board of Directors in April 2012. ... The Audit Committee currently consists of Mr. Sarma and Dr. Malik. ... The Compensation Committee currently consists of Dr. Malik and Mr. Sarma. ... The Conflicts Committee currently consists of Ambassador Black, Dr. Malik, and Mr. Sarma. ... The Nominations Committee currently consists of Dr. Malik, as Mr. Jasinowski, who previously served on the Nominations Committee, recently retired for medical reasons. ... The non-executive independent directors were compensated on a monthly basis $12,500 ($150,000 annually) ...